GaDia develops rapid diagnostic tests for antimicrobial resistance, combining product innovation, regulatory progress and research partnerships.
GaDia advances rapid diagnostics for antimicrobial resistance Read More »
Integrated into the Bachem Group since 2001, the Vionnaz site brings over five decades of expertise in small molecule synthesis to Valais’ pharmaceutical manufacturing landscape. Its competencies in amino acid chemistry, electrochemistry and biocatalysis position it as a specialized contributor within Bachem’s global production network.
Bachem Vionnaz: Fine chemistry capabilities, supporting complex API manufacturing Read More »
Bioscibex, a biotech startup based at BioArk Monthey, has reached the semi-finals of the >>venture>> 2026 competition, one of Switzerland’s leading startup prizes.
Bioscibex reaches semi-finals of one of Switzerland’s leading startup competitions Read More »
A recent ACS Sensors study shows how signal amplification improves the sensitivity of point-of-care diagnostic assays, enabling faster and more reliable detection of low-concentration biomarkers.
Enhancing diagnostic sensitivity for real-world use Read More »
A new cross-border project supported by the Interreg VI-A Italy–Switzerland program has been launched to address antimicrobial resistance (AMR), a growing challenge for healthcare systems.
Notrixx, a startup from HES-SO Valais based in Sion, develops a biomarker-based test to improve detection of bacterial contamination in pharmaceuticals.
Notrixx advances biomarker-based detection of bacterial contamination in pharmaceuticals Read More »
Established in 1983 in Gamsen (Brig-Glis), Valsynthèse is a Valais-based company specializing in fine chemical synthesis and high-risk chemical processes. As a subsidiary of Société Suisse des Explosifs (SSE), the company operates at the interface of complex chemistry, industrial safety, and custom manufacturing for demanding applications.
Valsynthèse: Industrial Expertise in Fine and High-Risk Chemistry Rooted in Valais Read More »
Within the Digital Life Sciences programme at HES-SO Valais-Wallis, students learn to design applied AI systems through real-world projects. NutriGuard AI demonstrates how artificial intelligence can be integrated into life-science quality assessment workflows.
Digital Life Sciences: Turning artificial intelligence into applied solutions Read More »
Meet us at SC2-Valais Cluster ! BioArk will take part in Swiss Biotech Day 2026, taking place in Basel on May 4-5, 2026.
Valais Cluster at Swiss Biotech Day 2026 Read More »
At the Business Ideas event in Sion, CEIDOS shared its journey from early support to industrial validation in advanced cell therapy manufacturing.
CEIDOS shares early market lessons at the Business Ideas event series in Sion Read More »
